Financial insights of CDNA

MyFinsight

For the quarter ending 2026-03-31, CDNA made $117,700K in revenue. $2,809K in net income. Net profit margin of 2.39%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenue	117,700	108,386	100,055	86,679
Cost of testing services, product, patient and digital solutions-Service	17,097	18,120*	14,705	15,406
Cost of testing services, product, patient and digital solutions-Product	4,834	7,038*	5,629	4,981
Cost of testing services, product, patient and digital solutions-Patient And Digital Solutions	11,698	10,355*	10,320	8,271
Research and development	21,416	19,306	16,769	16,830
Sales and marketing	30,373	30,924	24,449	24,279
General and administrative	30,484	28,684	28,429	27,683
Litigation settlement expense	-600	0	0	-350
Total operating expenses	116,502	114,426	100,301	97,800
Income (loss) from operations	1,198	-6,040	-246	-11,121
Interest income, net	1,909	2,013	2,013	2,364
Other (expense) income, net	-330	264	-107	72
Total other income	1,579	2,277	1,906	2,436
Income (loss) before income taxes	2,777	-3,763	1,660	-8,685
Income tax benefit (expense)	-32	345	-15	-117
Net income (loss)	2,809	-4,108	1,675	-8,568

Basic EPS	0.05	-0.08	0.03	-0.16
Diluted EPS	0.05	-0.082	0.03	-0.16
Basic Average Shares	51,151,794	51,075,389	52,507,582	54,304,754
Diluted Average Shares	53,129,928	49,846,181	53,736,790	54,304,754

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.